Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry
作者:Aurangazeb Kabir、Satoshi Endo、Naoki Toyooka、Mayuko Fukuoka、Kazuo Kuwata、Yuji O. Kamatari
DOI:10.1093/jb/mvw063
日期:——
Inhibitors of AKR1B10 belonging to the aldo-keto reductase (AKR) superfamily are considered promising candidates for anti-cancer drugs. AKR1B1, a structurally similar isoform of AKR1B10, is involved in glucose metabolism. Thus, selective inhibition of AKR1B10 is required for the development of anti-cancer drugs. In this study, we first compared correlations between melting temperature and the 50% inhibition
属于醛酮还原酶(AKR)超家族的AKR1B10抑制剂被认为是抗癌药物的有前途的候选药物。AKR1B1是AKR1B10的结构相似的同工型,参与葡萄糖代谢。因此,开发抗癌药物需要选择性抑制AKR1B10。在这项研究中,我们首先比较了分别通过差示扫描荧光法(DSF)和酶抑制实验获得的熔融温度与50%抑制浓度之间的相关性,发现除了低溶解度的化合物外,还具有良好的相关性。该结果表明DSF方法可用于AKR超家族的药物筛选。然后,我们评估了它们作为针对所有七个主要人类AKR1家族蛋白抑制剂的选择性,并发现C18对AKR1B10最特异。